In AD, elevated levels of CatB have been detected in brains of AD patients extracellularly near neuritic plaques in membrane bound organelles, in degenerating neuronal perikarya, and in reactive astrocytes (Cataldo and Nixon, 1990; Cataldo et al., 1991; Nakamura et al., 1991). This evidence concerns the gene TYRP1 and Alzheimer disease.